TelomEye Pharmaceuticals
Burlington
About TelomEye Pharmaceuticals
TelomEye Pharmaceuticals creates an innovative therapeutic strategy to stop or reduce the progression of several serious ophthalmologic illnesses, particularly those related to aging. They offer a range of treatment options to keep eyesight clear. TelomEye prevents or slows the progression of very common ophthalmologic disorders, thereby minimizing the impact on the lives of a large number of people from all over the world.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $1.0M
- Funding stage: Seed
- Last round: Seed (Nov 2022)
- Website: telomeye.ca
- Phone: +1 647-675-7775
Industries & Categories
Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/telomeye-pharmaceuticals-198245 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.